Alzheimer's & Cognition
News
Watchdog group demands removal of FDA leaders after aducanumab approval
“This decision is a disastrous blow to the agency’s credibility, public health, and the financial sustainability of the Medicare program,” critic...
Conference Coverage
Photobiomodulation: Evaluation in a wide range of medical specialties underway
The therapy is used to treat a wide variety of medical and aesthetic disorders including acne vulgaris, psoriasis, burns, and wound healing.
Feature
The aducanumab revolution
As the controversial new Alzheimer’s drug makes its way from research settings to the clinic, practitioners brace for a potential sea change in...
Latest News
FDA approves controversial Alzheimer’s drug aducanumab (Aduhelm)
Approval was granted despite an FDA advisory panel recommendation not to approve the drug.
Feature
The end of happy hour? No safe level of alcohol for the brain
No evidence was found showing that the risk for alcohol-related brain harm differs according to the type of alcohol consumed (wine, beer, or...
Conference Coverage
When to refer patients with new memory loss
Initial questions should zero in on what the patient is forgetting, according to an expert.
Conference Coverage
Rituximab benefits seen in neuropsychiatric lupus
Findings from the largest prospective study of rituximab for NPSLE to date show signs of rituximab’s efficacy in reducing neuropsychiatric disease...
Feature
Age-related cognitive decline not inevitable?
‘Cognitive decline is not inevitable,’ says an author of a new paper.
News
Despite risks and warnings, CNS polypharmacy is prevalent among patients with dementia
The risks of these medications, particularly in combination, are almost certainly greater than the potential benefits.
Conference Coverage
Novel Alzheimer’s drug slows cognitive decline in phase 2 trial
The Alzheimer’s Association is encouraged by the promising data, according to Maria Carrillo, PhD, chief science officer for the organization.
News
Palliative care for patients with dementia: When to refer?
A systematic literature review finds few consistent criteria for referrals save for disease stage. Researchers argue that patients’ needs may be...